Key Concepts in Growth Factor Signaling and Oncogenic Pathways

Growth Factors (GFs)

Naturally occurring substances (usually proteins) capable of stimulating cellular growth, proliferation, and differentiation.

Ligand

A signaling molecule (like a growth factor) that binds specifically to a receptor to initiate a cellular response.

Receptor Tyrosine Kinase (RTK)

A class of high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. Examples include EGF-R, PDGF-R, and Kit.

Dimerization

The process where two receptors come together to form a pair after ligand binding; this is a critical step for activating RTKs.

Transphosphorylation (Autophosphorylation)

A process in which each member of a receptor pair phosphorylates the tyrosine residues on the cytoplasmic tail of its partner.

Ligand-Independent Firing

Receptors fire signals constantly even without a growth factor present, often due to structural mutations.

Example of Ligand-Independent Firing

v-ErbB: A truncated version of EGFR that lacks the ectodomain and is constitutively active.

Autocrine Signaling

Activation of the GF gene in a cell that already expresses that GF's receptor.

Example of Autocrine Signaling

A cancer cell produces its own growth factors to stimulate its own receptors, creating a self-perpetuating loop.

Overexpression

Excessive numbers of receptors on the cell surface lead to spontaneous collisions and firing.

Example of Overexpression

Ros-FIG or TrkA-Tpm3 fusions.

Gene Fusion

Chromosomal translocation fuses a receptor to a partner protein that naturally dimerizes, forcing the receptor to stay 'on'.

EGF Signaling (Epidermal Growth Factor)

The Receptor: EGF-R (ErbB1). Mechanism: Ligand binding → Dimerization → Transphosphorylation of C-terminal tails → Recruitment of downstream signaling molecules.

Significance of EGF Signaling

Frequently amplified or mutated in various epithelial cancers.

Kit Receptor

Type: Tyrosine Kinase. Ligand: SCF (Stem Cell Factor). Normal Function: Critical for hematopoiesis and pacemaker cells in the intestine.

Oncogenic Mutation in Kit Receptor

Mutations in the juxtamembrane (JM) domain remove inhibitory control, leading to GIST (Gastrointestinal Stromal Tumors).

JAK-STAT Signaling

Ligands: Cytokines (e.g., Erythropoietin/Epo, Interferon). Mechanism: These receptors do not have intrinsic kinase activity. Instead, they interact non-covalently with JAK (Janus Kinase).

Transcription Factor in JAK-STAT Signaling

Activation leads to the phosphorylation and dimerization of STAT proteins, which then move to the nucleus.

TGF-$\beta$ (Transforming Growth Factor-beta)

Type: Serine/Threonine Kinase Receptor (unlike the tyrosine kinases above). Structure: Forms a heterodimer (Type I and Type II receptors).

Function of TGF-$\beta$

Main regulator of blood vessel formation and bone growth. Crucially, it often acts to inhibit cell growth in normal cells.

Downstream Effectors of TGF-$\beta$

Activates SMADs, which function as transcription factors.